Benjamin Hohl - 13 Feb 2024 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELVN	Stock Option (right to buy)	Award	$0	+185,000		$0.000000	185,000	13 Feb 2024	Common Stock	185,000	$14.85	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	1/4th of the shares subject to the option will vest on February 13, 2025 and 1/48th of the shares subject to the option will vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.